Johnson & Johnson said Monday it agreed to a $5.5 billion commitment to resolve litigation over claims that its talc products caused ovarian cancer, according to Bloomberg.
The agreement is meant to settle the cancer claims tied to the company’s talc products.
J&J Agrees to $5.5 Billion Talc Cancer Settlement
2026-07-27 23:03:08
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
英国食品通胀连续第六个月回落Next article：
No next page found
